These TGF‐β enhancers could be used to prevent and treat the majority (carcinoma) of human cancers,69 and other chronic inflammatory diseases such as atherosclerotic cardiovascular disease (ASCVD).77, 78. The gene discussed is TGFB1; the disease is atherosclerosis.